Professor, Xuanwu Hospital of Capital Medical University
We are delighted to announce that Professor Chan Piu, Professor and Director at Xuanwu Hospital of Capital Medical University, will be attending the BIOHK2024 conference held in Hong Kong in September 2024.
Professor Chan Piu is an immensely well-known figure in the neuroscience realm. His vast knowledge in neurodegenerative disorders and age-related disorders will be a focus of the BIOHK2024 conference. We sincerely welcome Professor Chan Piu to participate in BIOHK2024 and look forward to his speech at the upcoming conference.
The following briefly introduces Professor Chan’s achievements:
He is currently a Professor and Director in the Department of Geriatrics, Neurology, and Neurobiology and is well known for his current development of models for CNS diseases. Additionally, he has been studying familial and susceptibility genes and a variety of biomarkers for Parkinson’s and Alzheimer’s. Furthermore, he is the Director of the National Centre of GCP Trials for Neurodegenerative Disorders and has been the PI for 6 registration clinical trials. He is also a frequent consultant for the State Food and Drug Administration of China. Professor Chan is a committee member for the Movement Disorder Society (MDS) “Task Force on the definition of Parkinson’s disease” and “Telemedicine Task Force”. Furthermore, he has published over 250 peer-reviewed papers and served as editorial members of over 15 international and Chinese journals. Currently, Professor Chan is the Director of the Parkinson Disease Centre of Beijing Institute for Brain Disorders and Vice President of the Chinese Society of Gerontology and Geriatrics. Furthermore, he is vice President of the Chinese Association of Geriatrics, General Secretary of Society of Geriatrics of the Chinese Doctor’s Association, and a committee member of the Society of Geriatrics of the Chinese Association of Medical. He is the director of the Chinese Parkinson Study Group and deputy director of Committee on Parkinson’s disease and Movement Disorders of the Chinese Neurology Association. He has been the Deputy Director and Principal Investigator of Chinese National Human Genome Centre Beijing since 2001.